Full Text View
Tabular View
No Study Results Posted
Related Studies
T Cell Response in Hypersensitivity Syndrome
This study has been completed.
First Received: September 13, 2005   Last Updated: March 19, 2007   History of Changes
Sponsored by: University Hospital, Rouen
Information provided by: University Hospital, Rouen
ClinicalTrials.gov Identifier: NCT00213447
  Purpose

immunological study of the T cell repertoire phenotype and functionality in hypersensitivity syndrome.


Condition
Hypersensitivity
Syndrome

MedlinePlus related topics: Allergy
U.S. FDA Resources
Study Type: Observational
Study Design: Longitudinal, Defined Population, Prospective Study
Official Title: Characterization of T Cell Response in Hypersensitivity Syndrome

Further study details as provided by University Hospital, Rouen:

Estimated Enrollment: 40
Study Start Date: November 2002
Estimated Study Completion Date: December 2005
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • age > 18
  • cutaneous eruption
  • lymph nodes
  • hepatitis
  • interstitial pneumonia
  • nephritis
  • cardiopathy
  • eosinophilia
  • hyperlymphocytosis

Exclusion Criteria:

  • age minor to 18
  • HIV +
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00213447

Locations
France
UH-Rouen
Rouen, France
Sponsors and Collaborators
University Hospital, Rouen
Investigators
Principal Investigator: Pascal Joly, MD-PHD UH rouen
  More Information

No publications provided

Study ID Numbers: 2001/056/HP
Study First Received: September 13, 2005
Last Updated: March 19, 2007
ClinicalTrials.gov Identifier: NCT00213447     History of Changes
Health Authority: France: Ministry of Health

Study placed in the following topic categories:
Hypersensitivity

Additional relevant MeSH terms:
Hypersensitivity
Pathologic Processes
Disease
Immune System Diseases
Syndrome

ClinicalTrials.gov processed this record on May 07, 2009